CATALAYER NEWS
Roche’s sefaxersen shows 43% proteinuria reduction in IgAN trial
Source: Investing.com · 2026-10-23
Full article text is available in the Catalayer news terminal.
MORE FROM INVESTING.COM
Can silver recover from its latest sell-off? UBS weighs in
2026-10-24
Woori Financial ADR earnings beat by $0.29, revenue topped estimates
2026-10-24
Amgen at ESMO: IMDELLTRA data points to earlier lung cancer use
2026-10-24
Apax, Nordic Capital and Dalmore circling UK supplier JLA Group - Bloomberg
2026-10-24
Exodus Movement director Margaret Knight sells $955 in stock
2026-10-24
RELATED ON CATALAYER
Mentioned Tickers
$ROG.SW · RocheRELATED MARKETS
Prediction Markets